1,105 research outputs found

    Advances in Alzheimer’s Disease Drug Development

    Get PDF

    Recent developments in Alzheimer's disease therapeutics

    Get PDF
    Alzheimer's disease is a devastating neurological disorder that affects more than 37 million people worldwide. The economic burden of Alzheimer's disease is massive; in the United States alone, the estimated direct and indirect annual cost of patient care is at least $100 billion. Current FDA-approved drugs for Alzheimer's disease do not prevent or reverse the disease, and provide only modest symptomatic benefits. Driven by the clear unmet medical need and a growing understanding of the molecular pathophysiology of Alzheimer's disease, the number of agents in development has increased dramatically in recent years. Truly *disease-modifying' therapies that target the underlying mechanisms of Alzheimer's disease have now reached late stages of human clinical trials. Primary targets include beta-amyloid, whose presence and accumulation in the brain is thought to contribute to the development of Alzheimer's disease, and tau protein which, when hyperphosphorylated, results in the self-assembly of tangles of paired helical filaments also believed to be involved in the pathogenesis of Alzheimer's disease. In this review, we briefly discuss the current status of Alzheimer's disease therapies under study, as well the scientific context in which they have been developed

    The AT(N) framework for Alzheimer\u27s disease in adults with Down syndrome

    Get PDF
    The National Institute on Aging in conjunction with the Alzheimer\u27s Association (NIA-AA) recently proposed a biological framework for defining the Alzheimer\u27s disease (AD) continuum. This new framework is based upon the key AD biomarkers (amyloid, tau, neurodegeneration, AT[N]) instead of clinical symptoms and represents the latest understanding that the pathological processes underlying AD begin decades before the manifestation of symptoms. By using these same biomarkers, individuals with Down syndrome (DS), who are genetically predisposed to developing AD, can also be placed more precisely along the AD continuum. The A/T(N) framework is therefore thought to provide an objective manner by which to select and enrich samples for clinical trials. This new framework is highly flexible and allows the addition of newly confirmed AD biomarkers into the existing AT(N) groups. As biomarkers for other pathological processes are validated, they can also be added to the AT(N) classification scheme, which will allow for better characterization and staging of AD in DS. These biological classifications can then be merged with clinical staging for an examination of factors that impact the biological and clinical progression of the disease. Here, we leverage previously published guidelines for the AT(N) framework to generate such a plan for AD among adults with DS

    Osteoblastic and Vascular Endothelial Niches, Their Control on Normal Hematopoietic Stem Cells, and Their Consequences on the Development of Leukemia

    Get PDF
    Stem cell self-renewal is regulated by intrinsic mechanisms and extrinsic signals mediated via specialized microenvironments called “niches.” The best-characterized stem cell is the hematopoietic stem cell (HSC). Self-renewal and differentiation ability of HSC are regulated by two major elements: endosteal and vascular regulatory elements. The osteoblastic niche localized at the inner surface of the bone cavity might serve as a reservoir for long-term HSC storage in a quiescent state. Whereas the vascular niche, which consists of sinusoidal endothelial cell lining blood vessel, provides an environment for short-term HSC proliferation and differentiation. Both niches act together to maintain hematopoietic homeostasis. In this paper, we provide some principles applying to the hematopoietic niches, which will be useful in the study and understanding of other stem cell niches. We will discuss altered microenvironment signaling leading to myeloid lineage disease. And finally, we will review some data on the development of acute myeloid leukemia from a subpopulation called leukemia-initiating cells (LIC), and we will discuss on the emerging evidences supporting the influence of the microenvironment on chemotherapy resistance

    Evolutionary concept analysis of health seeking behavior in nursing: A systematic review

    Get PDF
    Background: Although the research in health seeking behavior has been evolving, its concept remains ambiguous. Concept clarification, as a central basis of developing knowledge, plays an undeniable role in the formation of nursing sciences. As the initial step toward the development of theories and theoretical models, concept analysis is broadly used through which the goals can be used and tested. The aim of this study was to report an analysis of the concept of "health seeking behavior". Method: Employing a rigorous evolutionary concept analysis approach, the concept of health seeking behavior was examined for its implications, use, and significance in the discipline of nursing between 2000 and 2012. After applying inclusion and exclusion criteria, a total of 40 articles and 3 books were selected for the final analysis. Results: The definition of attributes, antecedents, and consequences of health seeking behavior was performed through concept analysis. Core attributes (interactional, processing, intellectual, active, decision making based and measurable) were studied. The antecedents of concept were categorized as social, cultural, economic, disease pattern and issues related to health services. Health-seeking behavior resulted in health promotion and disease risk reduction. In addition, it led to predicting the future probable burden of the diseases, facilitation of the health status, early diagnosis, complete and effective treatment, and complication control. Conclusion: Health-seeking behavior, as a multi-dimensional concept, relies on time and context. An awareness of health-seeking behavior attributes antecedents and consequences results in promoting the status, importance and application of this concept in the nursing profession. �© 2015 Poortaghi et al

    Effect of drought stress on growth, proline and antioxidant enzyme activities of upland rice

    Get PDF
    Responses of eight upland rice (Oryza sativa L.) varieties subjected to different drought levels were investigated in laboratory to evaluate eight local upland rice varieties against five drought levels (0, -2, -4, -6, and -8 bars) at germination and early seedling growth stage of plant development. Data were analyzed statistically for growth parameters; shoot length, root length, and dry matter yield, and biochemical parameters; proline and antioxidant enzymes activity (catalase, superoxide dismutase and peroxidase), were measured. Experiment units were arranged factorial completely randomized design with four replications. The drought-tolerant variety, Pulot Wangi tolerated PEG at the highest drought level (-8 bar) and showed no significantly difference relation to control. However, drought-sensitive variety, Kusam was markedly affected even at the lowest drought level used. Concomitantly, the activity of antioxidant enzymes catalase, peroxidase and superoxide dismutase in the drought-tolerant varieties increased markedly during drought stress, while decreased by drought stress in the drought sensitive variety. Consequently, this led to a marked difference in the accumulation of proline in the upland rice varieties. It may be concluded that the activities of antioxidant enzymes and proline accumulation were associated with the dry mass production and consequently with the drought tolerance of the upland rice varieties
    corecore